INSIGHTS ON DRUG DEVELOPMENT
-
Collaborating For A Sustainable Future
Explore how cross-industry partnerships are driving sustainable process intensification to enable faster innovation, reduced waste, and long-term progress through shared goals and scalable solutions.
-
Monolithic Columns As Downstream Processing Solutions For Lentiviral Purification
Third-generation lentiviral vectors enable efficient gene delivery, but purification challenges limit in vivo applications. Monolithic columns and advanced assays show promise for downstream processes.
-
Achieving Optimal CAR-T Cell Generation
Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.
-
What Are ATMPs And Why Do They Matter?
Delves into the evolution of Advanced Therapy Medicinal Products (ATMPs), exploring their complex development, revolutionary potential in treating diseases, and the intricacies of cell and gene therapies.
-
Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology5/1/2024
Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.
-
Assessing Particle Generation In A Single-Use Mixing System11/13/2025
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
A Lean, Agile Business Model To Deliver High-Quality Oncologic Treatments12/11/2023
No two journeys through the drug pipeline are the same; the ability to leverage a variety of approaches for different products is what sets one lean biotech company apart.
-
Process Intensification: Your Guide To "Doing More With Less"8/5/2025
Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.
-
How A Privately Owned CDMO Is Transforming Client Expectations5/16/2024
Finding a partner with flexible services and a strong emphasis on building long-term client relationships can help ensure success for your pharmaceutical product.
DRUG DEVELOPMENT SOLUTIONS
-
Uniquely Ergonomic System Microscope Leica DM1000
The ergonomically designed Leica DM1000 with adjustable features and easy-to-use controls adapts to every user to improve comfort and convenience while working at the microscope.
Featuring high-quality optical performance, the Leica DM1000 is ideal for all clinical laboratory applications, in particular cytology, haematology, and pathology. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
Its advanced capabilities, including fluorescence, make it well suited also for complex tasks.
-
Sartorius is a leading provider of Cell Line Development Services allowing customers easy open access to a cost effective reliable technology platform. The Cellca CHO Expression Platform consistently delivers well characterized stable research clones from DNA to Research Cell Bank (RCB) in just 14 weeks with average titers of 4 g/L in an easily scalable fed batch process.
-
S APO Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
-
Platform of automated, single-use systems for tangential flow filtration at multiple scales.